Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual orally disintegrating olanzapine for breakthrough CINV
TCTR20251008001Phase 2Completed
- Sponsor
- Chulalongkorn University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV), sponsored by Chulalongkorn University. Started Sep 2025; status: completed.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on TCTR20251008001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251008001.